# A Study of TTYP01 in Healthy Adult Subjects

> **NCT04370431** · PHASE1 · COMPLETED · sponsor: **Shanghai Auzone Biological Technology Co., Ltd.** · enrollment: 72 (actual)

## Conditions studied

- Healthy Adult Subjects

## Interventions

- **DRUG:** TTYP01 single ascending doses
- **DRUG:** Placebo
- **DRUG:** TTYP01, 60 mg
- **DRUG:** TTYP01, 120 mg
- **DRUG:** Radicut® (ampoule), 30 mg
- **DRUG:** Radicut® (bag) , 60 mg
- **DRUG:** TTYP01, up to 120 mg

## Key facts

- **NCT ID:** NCT04370431
- **Lead sponsor:** Shanghai Auzone Biological Technology Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-04-24
- **Primary completion:** 2020-12-17
- **Final completion:** 2021-01-08
- **Target enrollment:** 72 (ACTUAL)
- **Last updated:** 2025-01-06

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04370431

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04370431, "A Study of TTYP01 in Healthy Adult Subjects". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04370431. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*